Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Analyzing Stepans Recent Insider Trading and Financial Performance

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Exploring Stepan‘s Insider Trading Activity

F. Quinn Stepan, Jr., a member of the Board at Stepan (NYSE:SCL), recently executed a notable insider sell on March 12, 2024. Jr. offloaded 2,000 shares of Stepan, totaling $174,854 in a transaction revealed in an SEC filing. This action occurred while Stepan’s shares held steady at $88.75 during Tuesday morning trading.

Diving into Stepan’s Operations

Stepan Co operates in the chemical industry, manufacturing and distributing various chemical products through three distinct segments. The surfactants division, a key revenue driver, supplies cleaning agents for products like detergents, shampoos, and body wash. The polymers segment specializes in polyurethane for insulation and phthalic anhydride for plastic components. Lastly, the specialty products unit offers chemicals for food and flavoring purposes. Stepan primarily generates revenue from the U.S. market.

Insights into Financial Performance

Stepan has encountered financial challenges, experiencing a revenue decline of approximately -15.15% by December 31, 2023. This decrease signifies a drop in the company’s earnings compared to previous periods. Furthermore, Stepan’s growth rate has lagged behind industry peers in the Materials sector.

SCL Stock Price Declines by 1.79% on March 12, 2024: Whats Next for Investors?

On March 12, 2024, SCL stock experienced a slight decline in its performance. The stock opened at $88.91, which was $0.16 higher than its previous close. However, throughout the day, the price of SCL shares dropped by $1.59, resulting in a 1.79% decrease from the market’s last close. Despite this decrease, SCL is still trading in the middle of its 52-week range and near its 200-day simple moving average. Investors may be keeping a close eye on SCL’s price momentum to determine whether the stock will continue to decline or if it will rebound in the near future. It will be interesting to see how SCL stock performs in the coming days and whether it will be able to recover from the drop on March 12.

SCL Stock Performance Analysis: Revenue and Net Income Decline in 2024

On March 12, 2024, SCL stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $2.33 billion, which decreased by 16.14% compared to the previous year. In the fourth quarter, total revenue was $532.13 million, holding flat compared to the previous quarter.

Net income for the past year was $40.20 million, showing a significant decrease of 72.68% compared to the previous year. However, in the fourth quarter, the company reported a net loss of $1.19 million, which was an improvement from the previous quarter.

Earnings per share (EPS) for the past year was $1.75, which decreased by 72.54% compared to the previous year. In the fourth quarter, EPS was -$0.05, indicating a significant decrease of 109.54% compared to the previous quarter.

Overall, SCL stock showed a decline in total revenue, net income, and earnings per share compared to the previous year. However, there was a slight improvement in net income in the fourth quarter compared to the previous quarter. Investors and analysts may need to closely monitor the company’s financial performance and future outlook to make informed decisions about investing in SCL stock.

Tags: SCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Chair at Nucor Makes Significant Investment in Company

Finance_ Charts for stock trading

Analyst Phillip Jungwirths Recent Market Updates and Ratings

Roth MKM Analyst Maintains Neutral Rating on Kroger with Increased Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com